Latent tuberculosis infection: Difference between revisions

From IDWiki
No edit summary
Line 1: Line 1:
 
= Definition =
= Latent tuberculosis infection (LTBI) =
 
 
== Definition ==
 
   
 
* Prior exposure to TB
 
* Prior exposure to TB
 
* Goal is to identify those who are at increased risk of developing active TB and would benefit from treatment
 
* Goal is to identify those who are at increased risk of developing active TB and would benefit from treatment
   
== Investigations ==
+
= Investigations =
   
 
* Tuberculin skin test (TBST)
 
* Tuberculin skin test (TBST)
Line 14: Line 12:
 
** Preferred for those who have received BCG after infancy
 
** Preferred for those who have received BCG after infancy
   
== Positive TBST ==
+
= Positive TBST =
   
 
# Is it truly positive?
 
# Is it truly positive?
Line 30: Line 28:
 
#* baseline liver enzymes and vision testing
 
#* baseline liver enzymes and vision testing
   
== Reading ==
+
= Reading =
   
 
* [http://blogs.jwatch.org/hiv-id-observations/index.php/common-curbsides-the-tuberculin-skin-test-and-igra-that-dont-agree/2014/11/10/ TBST vs. IGRA for latent TB]
 
* [http://blogs.jwatch.org/hiv-id-observations/index.php/common-curbsides-the-tuberculin-skin-test-and-igra-that-dont-agree/2014/11/10/ TBST vs. IGRA for latent TB]
   
== Tools ==
+
= Tools =
   
 
* [http://www.tstin3d.com/en/calc.html TST in 3D online TBST/IGRA Interpreter]
 
* [http://www.tstin3d.com/en/calc.html TST in 3D online TBST/IGRA Interpreter]
  +
  +
[[Category:TB]]

Revision as of 22:28, 14 August 2019

Definition

  • Prior exposure to TB
  • Goal is to identify those who are at increased risk of developing active TB and would benefit from treatment

Investigations

  • Tuberculin skin test (TBST)
    • Sens 90%, Spec >95
  • Interferon-gamma release assay (IGRA)
    • Sn 95%, Sp >95%
    • Preferred for those who have received BCG after infancy

Positive TBST

  1. Is it truly positive?
    • Consider IGRA
    • BCG vaccine can be considered a cause of false positive when
      • vaccine given after 12 months of age, and
      • patient has no risk factors, and
      • either Canadian-born non-Aboriginal, or not from endemic country
  2. Rule out active TB
    • signs/symptoms
    • CXR or CT chest
    • Sputum x3 if coughing or cavitary lesions
  3. Evaluate risk of reactivation treatment
    • INH 300 daily x9 mo with pyridoxine
    • baseline liver enzymes and vision testing

Reading

Tools